Jul 21, 2025 · Library of Congress
Introduced in House
H.R. 4570
Status: In committee
Interagency Patent Coordination and Improvement Act of 2025
Interagency Patent Coordination and Improvement Act of 2025
Sponsored by Joe Neguse (Democrat-CO-2)
Cosponsors
0
Actions
3
Roll calls
0
Amendments
0
Related bills
1
Actions
Jul 21, 2025 · Library of Congress
Introduced in House
Jul 21, 2025 · House floor actions
Referred to the House Committee on the Judiciary.
Latest activity
Lobbying reported · Blue Cross And Blue Shield Of Florida · Jul 20
Blue Cross And Blue Shield Of Florida reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Of Florida — $80,000
BillsH.R. 668H.R. 1227H.R. 1254H.R. 1843H.R. 2041H.R. 2493H.R. 3164H.R. 3302H.R. 3419H.R. 3514H.R. 4077H.R. 4570H.R. 4710H.R. 5243H.R. 6248H.R. 6485H.R. 6837H.R. 7895H.R. 7973H.R. 8163H.R. 8201H.R. 8209H.R. 8684H.R. 8871H.R. 8883H.R. 9117H.R. 9389H.R. 9390H.R. 9392H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 43S. 380S. 1040S. 1041S. 1096S. 1302S. 1954S. 2355S. 2658S. 3014S. 3762S. 3799S. 4027S. 4189S. 4694
Lobbying reported · Pharmaceutical Research and Manufacturers of America (PhRMA) · Jul 20
Pharmaceutical Research and Manufacturers of America (PhRMA) reported 2nd Quarter (Apr 1 - June 30) lobbying for Pharmaceutical Research and Manufacturers of America (PhRMA) — $7,360,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5371H.R. 6089H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.R. 9661H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 1040S. 1041S. 1071S. 1096S. 1387S. 1414S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
Lobbying reported · Blue Cross And Blue Shield Association · Jul 20
Blue Cross And Blue Shield Association reported 2nd Quarter (Apr 1 - June 30) lobbying for Blue Cross And Blue Shield Association — $990,000
BillsH.R. 668H.R. 1227H.R. 1254H.R. 1843H.R. 2041H.R. 2493H.R. 3164H.R. 3302H.R. 3419H.R. 3514H.R. 4077H.R. 4570H.R. 4710H.R. 5243H.R. 6248H.R. 6485H.R. 6837H.R. 7895H.R. 7973H.R. 7996H.R. 8163H.R. 8201H.R. 8209H.R. 8684H.R. 8871H.R. 8883H.R. 9117H.R. 9389H.R. 9390H.R. 9392H.R. 9393H.R. 9395H.R. 9396H.R. 9397S. 43S. 380S. 1040S. 1041S. 1096S. 1302S. 1954S. 2355S. 2556S. 2658S. 3014S. 3762S. 3799S. 4027S. 4189S. 4694
Lobbying reported · Glaxosmithkline · Jul 16
Glaxosmithkline reported 2nd Quarter (Apr 1 - June 30) lobbying for Glaxosmithkline — $890,000
BillsH.Con.Res. 14H.R. 1H.R. 4H.R. 1262H.R. 1492H.R. 3160H.R. 3269H.R. 3521H.R. 4121H.R. 4317H.R. 4570H.R. 4780H.R. 5304H.R. 5342H.R. 5509H.R. 6423H.R. 6485H.R. 6610H.R. 6624H.R. 6938H.R. 7148H.R. 7391H.R. 7837H.R. 7953H.R. 8269H.R. 8646H.R. 8800H.R. 8845H.R. 9102H.R. 9142H.R. 9260H.R. 9310H.Res. 566S. 2S. 43S. 355S. 652S. 832S. 864S. 891S. 1040S. 1041S. 1071S. 1096S. 1414S. 1546S. 1553S. 1954S. 2256S. 2296S. 2354S. 2587S. 2620S. 2658S. 3014S. 3345S. 3452S. 3788S. 4784
You’re all caught up.